All the latest news on deals and dealmaking from around the world

Dow chief responds to Loeb pressure

Andrew Liveris promises to be a ‘great listener’


Investment banking league tables
This quarter’s global mergers and acquisitions activity and the deals and dealmakers involved

Norway consumed by Yara soap opera

Rare corporate drama plays out over collapsed merger talks with US rival CF Industries

Mylan tweaks $5bn ‘inversion’ deal

Drugs maker pushes on with Abbott unit purchase that will cut tax rate

China flexes its economic muscle

Turning point shows ongoing shift of global economic influence east

GSK’s chief Witty comes out fighting

Drugmaker ‘extremely pragmatic’ about options for boosting value


illustration of a private bank by Øivind Hovland ©Øivind Hovland

Switzerland, strategies, competition, crisis fallout, technology, emerging markets, recruitment, consolidation

illustration by Nick Lowndes ©Nick Lowndes

Insight into M&A in the technology, media and tele-communications sector

Twitter seeks developers and acquisitions

Social network looks to expand beyond messaging

BGC in hostile $675m bid for rival GFI

Interdealer broker acts after ‘delays’ in striking negotiated deal

Spirit revamp starts to pay off

Pubs group sets aside £75m to fund expansion of estate

Gorkana website

Media monitoring company Gorkana acquired

UK group under same umbrella as other PR organisations

Corporate writing stinks – blame the CEO

Standards have fallen and chief executives are responsible for what goes out in their name

Yahoo bites back as activists circle

Mayer mounts five-pronged defence of turnround efforts

Loeb urges Amgen to explore a break-up

Activist investor says biotech company is trading at a discount

Rail boss says worst ever gridlock looms

Canadian Pacific chief warns as quarterly net income rises 23%

How heavyweights took off overseas

The ambitious generation of 1970s and 1980s entrepreneurs took their start-ups to the top

Google leaps into new virtual reality

Technology group leads $542m investment in Magic Leap

Pacific Century Place Marunouchi

GIC sinks $1.7bn into Tokyo real estate

Singapore’s sovereign wealth fund buys landmark office block

BAE Systems makes cyber security push

Defence company pays $232.5m to increase foothold in US market

Bertelsmann purchase boosts education arm

Biggest acquisition for publisher since Random House

Shire CFO jumps ship for Severn Trent

Departure adds to disruption for drugs group

Valeant hints at higher bid for Allergan

Pharma group plays down talks of split with Pershing Square

Rolls-Royce aims to rebuild investor confidence

CEO faces up to reality of second profit warning in eight months

AbbVie hits at Treasury as Shire deal dies

González calls for comprehensive US tax reform

Credit Suisse sued over Azerbaijan venture

Georgian businessman claims bank failed to get best price


Vincent Bolloré repositions for next move

Decision to take control of advertising agency could presage sale

Willis in London insurance deal talks

Move highlights drive for consolidation in wholesale insurance

SHV buys Dutch animal feed group Nutreco

Family-owned trading company looks to diversify

Daisy accepts £500m investor buyout offer

Deal could position company to make further takeovers

What Lenovo can tell us about takeovers

An adaptable state of mind is more important than a fixed ‘way’ or template for integration

Ferrovial in A$1bn bid for Transfield

Shares in Australian infrastructure group up 27% on Spanish offer

IBM pays $1.5bn to shed chipmaking arm

Deal to offload lossmaking arm to GlobalFoundries

This is an undated company handout photograph of Arysta LifeScience Corp.'s agricultural chemicals, released to the media on Monday, Nov. 19, 2007. Permira Advisory LLP, which manages Europe's biggest buyout fund, agreed last month to buy Arysta from Olympus Capital Holdings Asia, a Hong Kong-based private-equity firm, for 250 billion yen in Japan's biggest buyout this year. Source: Arysta LifeScience Corp. via Bloomberg News

Platform Specialty grabs Arysta for $3.5bn

Ackman-backed chemical group will double its size with Irish deal

M&A deal failure at highest since 2008

A total of $573bn worth of deals have been withdrawn so far

Will the bond king’s reign benefit Janus?

Questions asked about the long-term future of Bill Gross

Hopes rise Widodo will hasten Indonesia SOE reforms

Sector with revenues equivalent to 18% of GDP in need of overhaul

Daisy Group receives £500m offer

Toscafund teams up with group of investors in 185p per share cash approach

Old Mutual buys Quilter Cheviot for £543m

Bridgepoint to reap return of three times initial investment

Buyers line up for AmREIT shopping malls

Competing bids could value the landlord at as much as $26 a share

Pfizer’s Astra pursuit suffers setback

Collapse of AbbVie’s bid for Shire diminishes chances of revised offer

BG settles on quiet Nordic efficiency

Lund was one of oil sector’s best-regarded chiefs at Statoil

week in review

Week in Review, October 18

UBS, EDF, Abbvie and Shire, and luxury groups featured